Objective 5 Clause Samples
Objective 5 is a clause that outlines a specific goal or target that the parties to an agreement aim to achieve. Typically, such a clause will detail the intended outcome, such as improving efficiency, meeting a regulatory requirement, or achieving a particular performance metric. For example, it might require the implementation of a new process or the attainment of a certain level of service quality. The core function of this clause is to provide clear direction and measurable benchmarks, ensuring all parties understand and work towards a common objective.
Objective 5. To improve the capacity of Range States and international cooperation and capacity towards the conservation of migratory waterbird species and their flyways (AP Headings: E, F)
5.1 The membership of the Agreement is expanded;
5.2 Sufficient funding for the implementation of the SP is raised from different sources;
5.3 Cooperation with other MEAs and key partners is enhanced;
5.4 The Small Grants Fund (SGF)3 is activated;
5.5 The rate of submission of National Reports is increased;
5.6 Capacity of national staff to implement the Agreement is increased through proper training mechanisms;
5.7 Appropriate national coordination mechanisms for implementation of AEWA linking to national coordination mechanisms for other biodiversity MEAs are established;
5.8 AEWA is recognized by other biodiversity MEAs as an MEA whose effectiveness in protecting waterbirds can be used as an indicator for sustaining biodiversity on a global level.
Objective 5. To improve the capacity of the Range States for international cooperation and capacity towards the conservation of waterbird species and their flyways
Objective 5. Plan and support the delivery of training and education programs for health professionals and the community, including beneficiaries of Title V and XIX services.
Objective 5. Code Repository
Objective 5. In-patient survey / WP 7 Hospital Pharma Involvement of partners and target groups
Objective 5. To determine uncertainties in relation to the full MRT dose measurement chain from a primary standard to a range of commercial and non-commercial dosimetry calculation platforms. This includes image quantification (such as uncertainties in the selection of volumes of interest (VOI) and image reconstruction); integration of TACs, propagation of uncertainties in NTCP models, and determination of the overall evaluated uncertainty in the absorbed dose quantification process.